Several studies show that missing doses and an incorrect inhalation technique, are the most common pharmacological risks in patients with Chronic Obstructive Pulmonary Disease diagnosis. These are associated with an increase in Health-related costs, mainly due to an increase in the number of emergency visits, hospitalizations and switches of medication as a consequence of therapeutic failures.
Citation: Estrada JI, Restrepo AM, Herrera R, Arrieta J, Serna JA, et al. (2015) The Economic Impact of Pharmacotherapeutic Follow-Up in Copd Patients at a Health Care Institution in Medellin-Colombia. J Pharma Care Health Sys 2:137.